PHILIP D WORBOYS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PHILIP D WORBOYS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PHILIP D WORBOYS. PHILIP D WORBOYS is SVP, Research & Transl Science in Theravance Biopharma, Inc. ($TBPH) and SVP, Translational Science in Theravance Biopharma, Inc. ($TBPH).
Latest Insider Trading Transactions of PHILIP D WORBOYS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11 2021 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Research & Tra ... | Sell | S | 20.00 | 8,829 | 176,580 | 343,679 | 352.5 K to 343.7 K (-2.50 %) |
| Feb 10 2021 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Research & Tra ... | Grant | A | 0.00 | 65,000 | 0 | 384,395 | 319.4 K to 384.4 K (+20.35 %) |
| Aug 24 2020 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Research & Tra ... | Payment of Exercise | F | 18.22 | 4,804 | 87,529 | 328,448 | 333.3 K to 328.4 K (-1.44 %) |
| Aug 24 2020 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Research & Tra ... | Sell | S | 18.00 | 17,103 | 307,854 | 333,252 | 350.4 K to 333.3 K (-4.88 %) |
| May 22 2020 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Research & Tra ... | Payment of Exercise | F | 26.67 | 4,807 | 128,203 | 350,355 | 355.2 K to 350.4 K (-1.35 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Research & Tra ... | Payment of Exercise | F | 25.90 | 29,105 | 753,820 | 354,750 | 383.9 K to 354.8 K (-7.58 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Research & Tra ... | Grant | A | 0.00 | 54,000 | 0 | 383,855 | 329.9 K to 383.9 K (+16.37 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Research & Tra ... | Grant | A | 0.00 | 65,000 | 0 | 329,855 | 264.9 K to 329.9 K (+24.54 %) |
| Aug 22 2019 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 21.51 | 2,272 | 48,871 | 267,127 | 269.4 K to 267.1 K (-0.84 %) |
| May 22 2019 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 19.84 | 2,272 | 45,076 | 269,399 | 271.7 K to 269.4 K (-0.84 %) |
| Feb 22 2019 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 27.00 | 3,986 | 107,622 | 270,644 | 274.6 K to 270.6 K (-1.45 %) |
| Feb 07 2019 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Grant | A | 0.00 | 47,250 | 0 | 274,630 | 227.4 K to 274.6 K (+20.78 %) |
| Feb 07 2019 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Grant | A | 0.00 | 65,000 | 0 | 227,380 | 162.4 K to 227.4 K (+40.03 %) |
| Nov 21 2018 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 24.79 | 4,373 | 108,407 | 162,380 | 166.8 K to 162.4 K (-2.62 %) |
| Sep 14 2018 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Sell | S | 28.50 | 6,393 | 182,201 | 166,753 | 173.1 K to 166.8 K (-3.69 %) |
| Aug 22 2018 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 26.95 | 5,508 | 148,441 | 173,146 | 178.7 K to 173.1 K (-3.08 %) |
| May 22 2018 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 24.31 | 19,524 | 474,628 | 178,654 | 198.2 K to 178.7 K (-9.85 %) |
| May 16 2018 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Grant | A | 0.00 | 33,750 | 0 | 198,178 | 164.4 K to 198.2 K (+20.53 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 29.09 | 4,566 | 132,825 | 163,563 | 168.1 K to 163.6 K (-2.72 %) |
| Feb 14 2018 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Grant | A | 0.00 | 9,000 | 0 | 168,129 | 159.1 K to 168.1 K (+5.66 %) |
| Nov 22 2017 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 28.58 | 5,503 | 157,276 | 159,129 | 164.6 K to 159.1 K (-3.34 %) |
| Aug 22 2017 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 27.40 | 5,502 | 150,755 | 164,632 | 170.1 K to 164.6 K (-3.23 %) |
| May 23 2017 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 36.83 | 5,503 | 202,675 | 170,134 | 175.6 K to 170.1 K (-3.13 %) |
| Feb 22 2017 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 33.78 | 10,397 | 351,211 | 173,935 | 184.3 K to 173.9 K (-5.64 %) |
| Feb 08 2017 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Grant | A | 0.00 | 9,000 | 0 | 184,332 | 175.3 K to 184.3 K (+5.13 %) |
| Nov 22 2016 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 31.96 | 2,104 | 67,244 | 175,332 | 177.4 K to 175.3 K (-1.19 %) |
| Aug 23 2016 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 27.89 | 2,104 | 58,681 | 177,436 | 179.5 K to 177.4 K (-1.17 %) |
| May 24 2016 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Payment of Exercise | F | 20.55 | 2,105 | 43,258 | 179,540 | 181.6 K to 179.5 K (-1.16 %) |
| Mar 17 2016 | TBPH | Theravance Biophar ... | WORBOYS PHILIP D | SVP, Translational ... | Grant | A | 0.00 | 105,000 | 0 | 179,943 | 74.9 K to 179.9 K (+140.11 %) |
Page: 1